The effect of selenium supplementation in the prevention of DNA damage in white blood cells of hemodialyzed patients: A pilot study

Biological Trace Element Research

Volumn 142, Issue 3, 2011, Pages 274-283

  Zachara, Bronislaw A ^a   Gromadzinska, Jolanta ^a   Palus, Jadwiga ^a   Zbrog, Zbigniew ^b   Swiech, Rafal ^b   Twardowska, Ewa ^a   Wasowicz, Wojciech ^a  

^a NOFER INSTITUTE OF OCCUPATIONAL MEDICINE   (Poland)

^b B Braun Avitum Dialysis Center   (Poland)

Author keywords

Chronic kidney disease; Comet assay; DNA damage; Hemodialysis; Selenium supplementation

Indexed keywords

DNA FORMAMIDOPYRIMIDINE GLYCOSYLASE; PLACEBO; SELENIUM;

ADULT; ARTICLE; BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DAMAGE; DNA STRAND BREAKAGE; DOUBLE BLIND PROCEDURE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HUMAN CELL; LEUKOCYTE; OXIDATIVE STRESS; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; SELENIUM BLOOD LEVEL; SUPPLEMENTATION;

ADULT; AGED; DNA DAMAGE; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; LEUKOCYTES; MALE; MIDDLE AGED; OXIDATIVE STRESS; RENAL DIALYSIS; SELENIUM;

SACCHAROMYCES CEREVISIAE;

EID: 80051782484     PISSN: 01634984     EISSN: 15590720     Source Type: Journal    
DOI: 10.1007/s12011-010-8776-0     Document Type: Article

References (69)

1. Kazi TG, Jalbani N, Kazi N, Jamali MK, Arain MB et al (2008) Evaluation of toxic metals in blood and urine samples of chronic renal failure patients, before and after dialysis. Ren Fail 30:737-345
2. Rucker D, Thadhani R, Tonelli M (2010) Trace element status in hemodialysis patients. Semin Dial, Jun 14 (Abstract)
3. Tonelli M, Wiebe N, Hemmelgarn B, Klarenbach S, Field C, Manns et al (2009) Trace elements in hemodialysis patients: a systematic review and meta-analysis. BMC Med 7:25
4. Taccone-Gallucci M, Noce A, Bertucci P, Fabbri C, Manca-di-Villahermosa S et al (2010) Chronic treatment with statins increases the availability of selenium in the antioxidant defence systems of hemodialysis patients. J Trace Elem Med Biol 24:27-30
5. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M (2006) Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 160:1-40 (Pubitemid 43227479)
6. Ames BN (2001) DNA damage from micronutrient deficiencies is likely to be a major cause of cancer. Mutat Res 475:7-20 (Pubitemid 32284938)
7. Castro L, Freeman BA (2001) Reactive oxygen species in human health and disease. Nutrition 17:161-165 (Pubitemid 32178295)
8. Mayne ST (2003) Antioxidant nutrients and chronic disease: use of biomarkers of exposure and oxidative stress status in epidemiologic research. J Nutr 133:933S-940S (Pubitemid 36262801)
9. Olinski R, Gackowski D, Foksinski M, Rozalski R, Roszkowski K et al (2002) Oxidative DNA damage: assessment of the role in carcinogenesis, atherosclerosis, and acquired immunodeficiency syndrome. Free Radic Biol Med 33:192-200 (Pubitemid 34775191)
10. Zachara BA, Gromadzinska J, Wasowicz W, Zbrog Z (2006) Red blood cell and plasma glutathione peroxidase activities and selenium concentration in patients with chronic kidney disease: a review. Acta Biochim Pol 53:663-677 (Pubitemid 46090116)
11. Combs GF Jr, Gray WP (1998) Chemopreventive agents: selenium. Pharmacol Ther 79:179-192 (Pubitemid 28393874)
12. Schrauzer GN (2003) The nutritional significance, metabolism and toxicology of selenomethionine. Adv Food Nutr Res 47:73-112 (Pubitemid 137640845)
13. Collins AR (2009) Investigating oxidative DNA damage and its repair using the comet assay. Mutat Res 681:24-32
14. Neve J, Chamart S, Molle L (1987) Optimization of direct procedure for the determination of selenium in plasma and erythrocytes using Zeeman effect atomic absorption spectroscopy. In: Bratter P, Schramel P (eds) Trace elements analytical chemistry in medicine and biology, vol 4. Walter de Gruyter, Berlin, Germany, pp 349-358
15. Singh NP, McCoy MT, Tice RR, Schneider EL (1988) A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 175:184-191
16. McKelvey-Martin VJ, Green MHL, Schmezer P, Pool-Zobel BL, De Meo MP et al (1993) The single cell gel electrophoresis assay (comet assay): a European review. Mutat Res 288:47-63 (Pubitemid 23193126)
17. Palus J, Dziubaltowska E, Rydzynski K (1999) DNA damage detected by the comet assay in the white blood cells of workers in a wooden furniture plant. Mutat Res 444:61-74 (Pubitemid 29341525)
18. Collins AR, Dobson VL, Dusinska M, Kennedy G, Stetina R (1997) The comet assay: what can it really tell us? Mutat Res 375:183-193 (Pubitemid 27226696)
19. Morrison DF (1990) Multivariate statistical methods (Polish edn) PWN. Warsaw, Poland
20. Senesse P (2009) Nutrition and oncogeriatry. Cancer Radiother 13:628-631
21. Letavayova L, Vlckova V, Brozmanova J (2006) Selenium: from cancer prevention to DNA damage. Toxicology 227:1-14 (Pubitemid 44402853)
22. Shamberger RJ, Willis CE (1971) Selenium distribution and human cancer mortality 2:211-221
23. Schrauzer GN, White DA, Schneider CJ (1977) Cancer mortality correlation studies-III: statistical associations with dietary selenium intakes. Bioinorg Chem 7:23-31
24. Bonomini M, Albertazzi A (1995) Selenium in uremia. Artif Organs 19:443-448
25. Zachara BA, Salak A, Koterska D, Manitius J,Wasowicz W(2004) Selenium and glutathione peroxidases in blood of patients with different stages of chronic renal failure. J Trace Elem Med Biol 17:291-299 (Pubitemid 38520269)
26. Zachara BA, Adamowicz A, Trafikowska U, Trafikowska A, Manitius J et al (2001) Selenium and glutathione levels, and glutathione peroxidase activities in blood components of uremic patients on hemodialysis supplemented with selenium and treated with erythropoietin. J Trace Elem Med Biol 15:201-208 (Pubitemid 34118135)
27. Richard MJ, Ducros V, Foret M, Arnaud J, Coudray C et al (1993) Reversal of selenium and zinc deficiencies in chronic hemodialysis patients by intravenous sodium selenite and zinc gluconate supplementation. Biol Trace Elem Res 39:149-159
28. Seo YR, Sweeney C, Smith ML (2002) Selenomethionine induction of DNA repair response in human fibroblasts. Oncogene 21:3663-3669 (Pubitemid 34620529)
29. Fisinin VI, Papazyan TT, Surai PF (2009) Producing selenium-enriched eggs and meat to improve the selenium status of the general population. Crit Rev Biotechnol 29:18-28
30. Ferguson LR, Philpott M, Karunasinghe N (2004) Dietary cancer and prevention using antimutagens. Toxicology 198:147-159 (Pubitemid 38609024)
31. Slupphaug G, Kavli B, Krokan HE (2003) The interacting pathways for prevention and repair of oxidative DNA damage. Mutat Res 531:231-251 (Pubitemid 37456735)
32. Yu S, Paetau-Robinson I (2006) Dietary supplements of vitamins E and C and beta-carotene reduce oxidative stress in cats with renal insufficiency. Vet Res Commun 30:403-413
33. Tarng DC, Huang TP, Wei YH, Liu TY, Chen HWet al (2000) 8-hydroxy-2'-deoxyguanosine of leukocyte DNA as a marker of oxidative stress in chronic hemodialysis patients. Am J Kidney Dis 36:934-944
34. Moller P, Loft S (2002) Oxidative DNA damage in human white blood cells in dietary antioxidant intervention studies. Am J Clin Nutr 76:303-310 (Pubitemid 34804049)
35. Sardas S, Izdes S, Ozcagli E, Kanbak O, Kadioglu E (2006) The role of antioxidant supplementation in occupational exposure to waste anaesthetic gases. Int Arch Occup Environ Health 80:154-159 (Pubitemid 44644637)
36. Kan E, Undeger U, Bali M, Basaran N (2002) Assessment of DNA strand breakage by the alkaline COMET assay in dialysis patients and the role of Vitamin E supplementation. Mutat Res 520:151-159 (Pubitemid 35247584)
37. Domenici FA, Vannucchi MT, Jordao AA Jr, Meirelles MS, Vannucchi H (2005) DNA oxidative damage in patients with dialysis treatment. Ren Fail 27:689-694 (Pubitemid 41748120)
38. Stopper H, Treutlein AT, Bahner U, Schupp N, Schmid U et al (2008) Reduction of the genomic damage level in haemodialysis patients by folic acid and vitamin B12 supplementation. Nephrol Dial Transplant 23:3272-3279
39. Cho KH, Kim HJ, Rodriguez-Iturbe B, Vaziri ND (2009) Niacin ameliorates oxidative stress, inflammation, proteinuria, and hypertension in rats with chronic renal failure. Am J Physiol Renal Physiol 297:F106-F113
40. Dziaman T, Huzarski T, Gackowski D, Rozalski R, Siomek A et al (2009) Elevated level of 8-oxo-7, 8- dihydro-2'-deoxyguanosine in leukocytes of BRCA1 mutation carriers compared to healthy controls. Int J Cancer 125:2209-2213
41. Collins AR (2004) The comet assay for DNA damage and repair. Principles, applications and limitations. Mol Biotechnol 26:249-261 (Pubitemid 41490465)
42. Hartmann A, Agurell E, Beevers C, Brendler-Schwaab S, Burlinson B et al (2003) Recommendations for conducting the in vivo alkaline Comet assay. 4th International Comet Assay Workshop. Mutagenesis 8:45-51 (Pubitemid 36118820)
43. Ribeiro DA, Campos RR, Bergamaschi CT (2009) Chronic renal failure induces genetic instability in multiple organs of Wistar rats. Eur J Clin Investig 39:289-295
44. Puchades Montesa M, Gonzalez Rico M, Solís Salguero M, Torregrosa Maicas I, Tormos Munoz M et al (2009) Study of oxidative stress in advanced kidney disease. Nefrologia 29:464-473
45. Tarng DC, Huang TP, Liu TY, Chen HW, Sung YJ et al (2000) Effect of vitamin E-bonded membrane on the 8-hydroxy 2'-deoxyguanosine level in leukocyte DNA of hemodialysis patients. Kidney Int 58:790-799
46. Schupp N, Stopper H, Rutkowski P, Kobras K, Nebel M et al (2006) Effect of different hemodialysis regimens on genomic damage in end-stage renal failure. Semin Nephrol 26:28-32 (Pubitemid 43075507)
47. Stopper H, Boullay F, Heidland A, Vienken J, Bahner U (2001) Comet-assay analysis identifies genomic damage in lymphocytes of uremic patients. Am J Kidney Dis 38:296-301
48. Horoz M, Bolukbas FF, Bolukbas C, Aslan M, Koylu AO et al (2006) The association of circulating leptin level with peripheral DNA damage in hemodialysis subjects. Clin Biochem 39:918-922 (Pubitemid 44344688)
49. Stewart JH, Buccianti G, Agodoa L, Gellert RT, McCredie MR et al (2003) Cancer of the kidney and urinary tract on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New Zealand. J Am Soc Nephrol 14:197-207 (Pubitemid 36026310)
50. Schupp N, Schmid U, Heidland A, Stopper H (2008) New approaches for the treatment of genomic damage in end-stage renal disease. J Ren Nutr 18:127-133 (Pubitemid 350251841)
51. Bellinger FP, Raman AV, Reeves MA, Berry MJ (2009) Regulation and function of selenoproteins in human disease. Biochem J 422:11-22
52. Reeves MA, Hoffmann PR (2009) The human selenoproteome: recent insights into functions and regulation. Cell Mol Life Sci 66:2457-2478
53. Valdiglesias V, Pasaro E, Mendez J, Laffon B (2010) In vitro evaluation of selenium genotoxic, cytotoxic, and protective effects: a review. Arch Toxicol 84:337-351
54. Papp LV, Lu J, Holmgren A, Khanna KK (2007) From selenium to selenoproteins: synthesis, identity, and their role in human health. Antioxid Redox Signal 9:775-806 (Pubitemid 46919583)
55. Squires J, Berry MJ (2006) Selenium, selenoproteins, and cancer. Hawaii Med J 65:239-240
56. Grotto D, Barcelos GRM, Valentini J, Antunes LM, Angeli JP et al (2009) Low level of methylmercury induce DNA damage in rats: protective effects of selenium. Arch Toxicol 83:249-254
57. Waters DJ, Shen S, Xu H, Kengeri SS, Cooley DM et al (2007) Noninvasive prediction of prostatic DNA damage by oxidative stress challenge of peripheral blood lymphocytes. Cancer Epidemiol Biomark Prev 16:1906-1910 (Pubitemid 47450526)
58. Li GX, Lee HJ, Wang Z, Hu H, Liao JD et al (2008) Superior in vivo inhibitory efficacy of methylseleninic acid against human prostate cancer over selenomethionine or selenite. Carcinogenesis 29:1005-1012 (Pubitemid 351982246)
59. Waters DJ, Shen S, Glickman LT, Cooley DM, Bostwick DG et al (2005) Prostate cancer risk and DNA damage: translational significance of selenium supplementation in a canine model. Carcinogenesis 26:1256-1262 (Pubitemid 41417903)
60. Dziaman T, Huzarski T, Gackowski D, Rozalski R, Siomek A et al (2009) Selenium supplementation reduced oxidative DNA damage in adnexectomized BRCA1 mutations carriers. Cancer Epidemiol Biomark Prev 8:2923-2928
61. Letavayová L, Vlasáková D, Spallholz JE, Brozmanová J, Chovanec M (2008) Toxicity and mutagenicity of selenium compounds in Saccharomyces cerevisiae. Mutat Res 638:1-10
62. Mániková D, Vlasáková D, Loduhová J, Letavayová L, Vigasová D et al (2009) Investigations on the role of base excision repair and non-homologous end-joining pathways in sodium selenite-induced toxicity and mutagenicity in Saccharomyces cerevisiae. Mutagenesis 25:155-162
63. Schrauzer GN (2009) Selenium and selenium-antagonistic elements in nutritional cancer prevention. Crit Rev Biotechnol 29:10-17
64. Schrauzer GN (2001) Nutritional selenium supplements: product types, quality, and safety. J Am Coll Nutr 20:1-4 (Pubitemid 32244958)
65. Schrauzer GN (2009) Lessons from the selenium and vitamin E cancer prevention trial (SELECT). Crit Rev Biotechnol 29:81
66. Rayman MP, Combs GF Jr, Waters DJ (2009) Selenium and vitamin E supplementation for cancer prevention. JAMA 301:39-51
67. Schrauzer GN (2000) Selenomethionine: a review of its nutritional significance, metabolism, and toxicity. J Nutr 130:1653-1656 (Pubitemid 30451048)
68. Fischer JL, Mihelc EM, Pollok KE, Smith ML et al (2007) Chemotherapeutic selectivity conferred by selenium: a role of p53-dependent DNA repair. Mol Cancer Ther 6:355-361 (Pubitemid 46206700)
69. Laffon B, Valdiglesias V, Pasaro E, Méndez J et al (2010) The organic selenium compound selenomethionine modulates bleomycin-induced DNA and repair in human leukocytes. Biol Trace Elem Res 133:12-19